Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University
Newcastle upon Tyne, NE1 8ST, United Kingdom
NCT Number: NCT04185948
This clinical trial attempts to evaluate the feasibility and acceptability of an intervention combining intermittent fasting and the Mediterranean diet guidelines vs an comparative intervention combining intermittent fasting but using the UK dietary guidelines.
Participants will be randomised to these intervention using a parallel design. Weight change and blood lipids will be assessed.
Looking for future studies?
Notify Me10 year–70 year
All sexes
Interventional
Not applicable
Newcastle upon Tyne, NE1 8ST, United Kingdom
This study will have a randomised parallel study comparing two interventions involving intermittent fasting. One of the interventions will use the Mediterranean dietary guidelines proposed by the Mediterranean Diet Foundation, the other intervention will use the UK dietary guidelines (Eatwell Guide).
In this study, the interventions will require participants to adopt these interventions for 4 weeks. A basic website containing support information will be develop for each of these interventions.
Baseline measurements will be taken at the start of the study. Blood samples will be obtained in a fasted state before and after 4-week study period.
Anthropometric and body composition measurements including height and weight, waist circumference, bioelectrical impedance will be collected by researcher. Physical activity will be assessed using accelerometers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Aged 18-70 yrs BMI 25-39.9kg/m2, Able to attend university for measurement and educational sessions.
Exclusion criteria
Cardiovascular problems or documented history of CVD including: angina; myocardial infarction; coronary revascularization procedures; stroke (ischemic or haemorrhagic, including transient ischemic attacks) symptomatic peripheral artery disease that required surgery or was diagnosed with vascular imaging techniques; ventricular arrhythmia; uncontrolled atrial fibrillation; congestive heart failure; hypertrophic myocardiopathy, or aortic aneurism,
Active malignant cancer or history of malignancy within the last 5 years (except non-melanoma skin cancer)
Issues affecting food intake e.g. dysphagia, severe allergies, food neophobia, strong dislike of foods in diet plan, or religious issues
Lack of motivation to change diet/lifestyle (low likelihood as calculated according to the Prochaska and DiClemente Stages of Change Model)
Lack of motivation to fast Medical reasons not allowing very low calorie intake, type 1 or 2 diabetes
Pregnancy or hoping to become pregnant, or breastfeeding
Current adherence to other weight loss or exercise program
Illiteracy or inability/unwillingness to give written informed consent or communicate with study staff
Institutionalization
History of surgical procedures for weight loss or intention to undergo bariatric surgery in the next 12 months
Obesity of known endocrine origin (e.g. hypothyroidism, polycystic ovarian syndrome)
Serious psychiatric disorders including: schizophrenia, bipolar disorder, eating disorders, or depression with hospitalization within the last 6 months
Alcohol abuse or addiction (or total daily alcohol intake >50 g) or drug abuse within the past 6 months
Current use of weight loss medication
For 4 weeks participants will be encouraged to adopt the Mediterranean dietary guidelines as recommended by the Mediterranean Diet Foundation in Barcelona, Spain. In combination with these guidelines, an intermittent fasting regime involving two days of the week will be implemented. The regime will encourage individuals to consume of 500kcal per day for women and 625kcal per day for men, resulting in 75% daily caloric restriction during each of these two days.
For 4 weeks participants will be encouraged to adopt the UK dietary guidelines (Eatwell Guide). In combination with these guidelines, an intermittent fasting regime involving two days of the week will be implemented. The regime will encourage individuals to consume of 500kcal per day for women and 625kcal per day for men, resulting in 75% daily caloric restriction during each of these two days.
Time frame: 4 weeks
Participants will complete a questionnaire directed to obtain early markers of how the intervention is used
Time frame: 4 weeks
Plasma levels of total cholesterol
Time frame: 4 weeks
Weight change after intervention
Time frame: 4 weeks
Participants will self-report dietary intake using the 24-hour dietary recall method. Three days (including 2 weekdays and 1 weekend day) of dietary intake at baseline and after two months will be reported.
Time frame: 4 weeks
Physical activity will be assessed assessed during seven days at baseline and after 2 months interventions by accelerometry.
Northumbria University
Other
A Pilot Study Investigating the Acceptability and Impact of the Mediterranean Diet and Intermittent Fasting
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05589129
Athletic Performance, Body Weight
Salt Lake City, Utah, United States
View Trial DetailsNCT05981508
Behavior, Behavior, Animal
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06564753
Body Weight, Body Weight Changes
Camperdown, New South Wales, Australia
View Trial DetailsNCT05061472
Appetitive Behavior, Behavior
Aurora, Colorado, United States
View Trial Details